Literature DB >> 12004056

Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo.

Paul S Amieux1, Douglas G Howe, Heidi Knickerbocker, David C Lee, Thomas Su, George S Laszlo, Rejean L Idzerda, G Stanley McKnight.   

Abstract

A targeted disruption of the RIalpha isoform of protein kinase A (PKA) was created by using homologous recombination in embryonic stem cells. Unlike the other regulatory and catalytic subunits of PKA, RIalpha is the only isoform that is essential for early embryonic development. RIalpha homozygous mutant embryos fail to develop a functional heart tube at E8.5 and are resorbed at approximately E10.5. Mutant embryos show significant growth retardation and developmental delay compared with wild type littermates from E7.5 to E10.5. The anterior-posterior axis of RIalpha mutants is well developed, with a prominent head structure but a reduced trunk. PKA activity measurements reveal an increased basal PKA activity in these embryos. Brachyury mRNA expression in the primitive streak of RIalpha mutants is significantly reduced, consistent with later deficits in axial, paraxial, and lateral plate mesodermal derivatives. This defect in the production and migration of mesoderm can be completely rescued by crossing RIalpha mutants to mice carrying a targeted disruption in the Calpha catalytic subunit, demonstrating that unregulated PKA activity rather than a specific loss of RIalpha is responsible for the phenotype. Primary embryonic fibroblasts from RIalpha mutant embryos display an abnormal cytoskeleton and an altered ability to migrate in cell culture. Our results demonstrate that unregulated PKA activity negatively affects growth factor-mediated mesoderm formation during early mouse development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004056     DOI: 10.1074/jbc.M200302200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  PRKAR1A and the evolution of pituitary tumors.

Authors:  Lawrence S Kirschner
Journal:  Mol Cell Endocrinol       Date:  2010-05-06       Impact factor: 4.102

2.  Neural crest-specific loss of Prkar1a causes perinatal lethality resulting from defects in intramembranous ossification.

Authors:  Georgette N Jones; Daphne R Pringle; Zhirong Yin; Michelle M Carlton; Kimerly A Powell; Michael B Weinstein; Ramiro E Toribio; Krista M D La Perle; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2010-06-09

3.  Designing isoform-specific peptide disruptors of protein kinase A localization.

Authors:  Lora L Burns-Hamuro; Yuliang Ma; Stefan Kammerer; Ulrich Reineke; Chris Self; Charles Cook; Gary L Olson; Charles R Cantor; Andreas Braun; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

4.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

5.  A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting.

Authors:  Hui Jin; Barbara Garmy-Susini; Christie J Avraamides; Konstantin Stoletov; Richard L Klemke; Judith A Varner
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

6.  An Isoform-Specific Myristylation Switch Targets Type II PKA Holoenzymes to Membranes.

Authors:  Ping Zhang; Feng Ye; Adam C Bastidas; Alexandr P Kornev; Jian Wu; Mark H Ginsberg; Susan S Taylor
Journal:  Structure       Date:  2015-08-13       Impact factor: 5.006

7.  Control of PKA stability and signalling by the RING ligase praja2.

Authors:  Luca Lignitto; Annalisa Carlucci; Maria Sepe; Eduard Stefan; Ornella Cuomo; Robert Nisticò; Antonella Scorziello; Claudia Savoia; Corrado Garbi; Lucio Annunziato; Antonio Feliciello
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

8.  Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism.

Authors:  Stefan Kammerer; Lora L Burns-Hamuro; Yuliang Ma; Sara C Hamon; Jaume M Canaves; Michael M Shi; Matthew R Nelson; Charles F Sing; Charles R Cantor; Susan S Taylor; Andreas Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

9.  Mys protein regulates protein kinase A activity by interacting with regulatory type Ialpha subunit during vertebrate development.

Authors:  Tomoya Kotani; Shun-ichiro Iemura; Tohru Natsume; Koichi Kawakami; Masakane Yamashita
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

10.  PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression.

Authors:  Alicia L Blaker; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.